activates hypothalamic MNCs increasing circulating AVP which acts at the kidneys to increase water reabsorption and maintain homeostasis. Conversely, decreased plasma osmolality is associated with inhibition of AVP MNCs, reduced plasma AVP and diuresis. A linear relationship between plasma AVP and osmolality is observed during normal conditions and requires highly coordinated excitatory and inhibitory postsynaptic responses. 3, 7 Altered synaptic homeostasis of vasopressinergic MNCs could contribute to disease conditions in which circulating AVP is abnormally elevated. 7, 8 For example, congestive heart failure and decompensated cirrhosis can be associated with dilutional hyponatraemia. [9] [10] [11] The development of hyponatraemia is associated with increased morbidity and mortality in these diseases. [12] [13] [14] Despite the vast amount of knowledge available about the regulation of AVP neurones, 5, 6, [15] [16] [17] [18] the pathophysiology of inappropriate AVP secretion remains unknown. Increased AVP release into systemic circulation from MNCs despite elevated mean arterial pressure (MAP) is reported during high salt loading (SL) (ie, giving rats only 2% NaCl to drink). 19 This makes salt loaded rats a suitable model for investigating changes in the neuronal regulation of AVP release as a result of chronic osmotic stress.
High salt intake causes hypernatraemia, leading to AVP release as feedback to maintain plasma osmolality. Salt-induced increases in and down-regulation of potassium chloride co-transporter (KCC2).
The changes in regulatory mechanisms create a feed forward loop causing sustained release of AVP and an increase in MAP. 19, 21, 22 However, the source of BDNF remains to be elucidated. We hypothesise that the SON is the source of BDNF contributing to increased AVP release and MAP in salt loaded rats. In the present study, we used adeno-associated viral vectors with short hairpin RNA (shRNA) against BDNF to test our hypothesis by knocking down BDNF in the SON. The findings of our study will address several critical gaps in the literature by determining the source of BDNF that contribute to neural adaptations resulting in pathophysiology of inappropriate AVP release in the high salt loaded rats.
| MATERIAL S AND ME THODS

| Animals
All of the experiments were conducted on outbred adult male Sprague-Dawley rats with a body weight of 200-250 g (Charles River, Wilmington, MA, USA). Rats were individually housed as a result of the use of survival surgery and individual fluid intake measurements in the protocol. All animals were maintained under a 12:12 hour light/dark photocycle in temperature-controlled environment with access to food and water available ad libitum unless otherwise indicated. Experimental protocols involving animals were approved by the UNT Health Science Center IACUC and were conducted in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. Survival surgeries were conducted using aseptic techniques. All rats were given procaine penicillin G (30 000 U, s.c.) and nonsteroidal antiinflammatory drug, carprofen (2 mg p.o.), was given before and after surgery for pain management.
| Adeno-associated virus (AAV)-mediated knockdown of BDNF in the SON
Rats were bilaterally injected in the SON (300 nL each side) with an AAV2 serotype conjugated with a shRNA directed against BDNF, a mCherry reporter and a U6 promoter (shBDNF). Another group of rats received bilateral SON injections of equal titre and amount of AAV2 conjugated with a scrambled (SCR) sequence of shRNA (Vector Biolabs, Malvern, PA, USA) as controls. The vectors were injected at a titre of 1.0 × 10 13 GC mL -1 (Vector Laboratories, Inc., Burlingame, CA, USA). Each rat was anaesthetised with isoflurane (2%-3%) and placed in a stereotaxic frame. Their skulls were exposed and levelled between lambda and bregma. 23 A micromanipulator was oriented to lower the probe to the targeted coordinates of SONs (1.4 mm posterior, 9.1 mm ventral and ±1.4 mm lateral from bregma). Each construct was injected in both the SONs over a 10-minute period. After 5 minutes, the injector was removed and the incision was closed with sutures.
| Metabolic cage study
After 2 weeks of recovery from surgery, rats were moved into metabolic cages (Lab Products, Seaford, DE, USA) for measurement of daily food intake, fluid intake and urine excretion. The rats were provided with ad libitum access to food and water for the first 7 days to record baseline parameters. Following the baseline measurements, a subset of shBDNF and SCR rats had their water replaced with 2% salt (NaCl)
to drink for 7 days as described previously. 19 Food and fluid intake were measured by filling the containers up to a predetermined weight (g) and subtracting the remaining weight 24 hours later. Mineral oil was added to the urine collection vials to prevent evaporation of water from urine. Urine excretion volume was recorded and urine samples were collected for measuring daily sodium excretion.
| Measurement of electrolyte concentration
Urine from each rat was collected in 50-mL centrifuge tubes and a 1-2 mL aliquot was taken from each daily sample and centrifuged (10 000 g for 20 minutes). The sodium concentration in each of the urine samples was determined at a dilution of 1:500 using a flame photometer (Jenway PFP7; VWR International, Radnor, PA, USA).
The final sodium concentration (mmol L -1 ) was calculated from a linear calibration curve derived from sodium standards.
| Laser capture microdissection (LCM) and quantitative real-time polymerase chain reaction (RT-PCR)
At the end of the 7-day salt loading protocol, rats were anaes- The housekeeping gene S18 was used to normalise RNA expression.
Melt curves generated were analysed to identify nonspecific products and primer-dimers. The data were analysed by the 2 
| Plasma measurements
Trunk blood (1-2 mL) was collected from each rat after decapitation and prepared for measuring plasma osmolality and haematocrit as described previously. 18 Plasma osmolality was measured on a vapor 
| Western blot analysis
At the end of 7-day salt loading protocol, the rats were anaesthetised with inactin (100 mg kg -1 i.p.) and decapitated. Punches containing the SON were collected from a 1-mm coronal section from each brain as described previously. 18, 28 Protein was extracted from the SON punches using RIPA lysis buffer containing dithiotreitol, chelators and protease phosphatase inhibitor cocktail. Protein concentration was determined by the BCA assay with varying concentrations of bovine serum albumin (BSA) as reference standards.
Total lysate (20-25 μg) was loaded onto a 4%-15% acrylamide sodium dodecyl sulphate (SDS) gel and separated by electrophoresis 
BDNF forward 5′-ATGACCATCCTTTTCCTTACTATGGT-3′
BDNF reverse 5′-TCTTCCCCTTTTAATGGTCAGTGTAC-3′
hnAVP forward 5′-GCCCTCACCTCTGCCTGCTA-3′
hnAVP reverse 5′-CCTGAACGGACCACAGTGGT-3′
S18 forward 5′-CAGAAGGACGTGAAGGATGG-3′
S18 reverse 5′-CAGTGGTCTTGGTGTGCTGA-3′
BDNF, brain-derived neurotrophic factor.
ab109684; Abcam, Cambridge, MA, USA); total TrkB (goat; dilu- 
| Mean arterial pressure (MAP) and heart rate measurements using radio telemetry
After 1 week of recovery from stereotaxic injections, some rats from each group were instrumented with radio telemetry transmitters (TA11PA-C40 telemetry unit; Data Science International, St
Paul, MN, USA) under isoflurane anaesthesia (2%-3%) as described previously. 29 The blood pressure catheter was advanced into the abdominal aorta and the radio transmitter device was placed in the peritoneal cavity for the duration of the experiment. Direct recording of MAP, heart rate and activity was performed using transmitters. After 2 weeks of recovery, signals from the telemetry device were recorded for 7-day baseline followed by 7-day SL using a Dataquest IV radio telemetry system (Data Sciences International).
During the experiments, heart rate, activity and MAP were all measured for 10 seconds every 10 minutes for 24 h d -1 and averaged as described previously. 
| Statistical analysis
In all of the above experiments, the rats were divided into four groups: (i) euhydrated rats injected with SCR virus (Eu SCR); (ii) euhydrated rats injected with shBDNF virus (Eu shBDNF); (iii) salt loaded rats injected with SCR virus (Salt SCR); and (iv) Salt loaded rats injected with shBDNF virus (Salt shBDNF).
Data from the metabolic cage studies and electrolyte measurements were analysed by separate two-way repeated measures ANOVA with time as first factor and treatment (drinking fluid with stereotaxic injection) as second factor, followed by Bonferroni posthoc tests. All other data were analysed using one-way ANOVA with
Bonferroni post-hoc tests using sigma plot, version 12.0 (Systat Software Inc., Chicago, IL, USA). Images were assembled using the 'magick' package in rstudio (Rstudio Inc., Boston, MA, USA). The group sizes were determined by power analysis and effect size as calculated from our previous work 16, 18, 19 and preliminary data using sigma plot, version 12.0. Power analysis calculation elements included considerations of P < 0.05, α of 0.8, largest difference between means, and the largest SD observed from our studies. The Eta 2 (η 2 )
method was chosen to calculate the effect sizes, and the sample sizes were balanced (equal) in all the groups and were independent of each other. Sum of squares of effect and the total from our previous studies 15, 16, 18, 19 were used for effect size determination. The minimal numbers per group for each experiment was determined to achieve an appropriately powered study with an effect size (η 2 ) of approximately 0.7 (70%). Data are reported as the mean ± SEM.
| RE SULTS
| Changes in AVP and BDNF gene expression in the SON
Using LCM, we verified the accuracy of the stereotaxic injections by visualising the mCherry reporter ( Figure 1A 
| Changes in phosphorylation of TrkB and KCC2 in the SON
We used mCherry expression to verify the specificity of stereotaxic injections (Figure 3 ). One-way ANOVA analysis revealed significant difference between the groups in TrKB phosphorylation (F 3,23 = 6.778, P < 0.05) and KCC2 phosphorylation ( 
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intake (Time × Treatment F 39,351 = 18.420, P < 0.001) ( Figure 4C ).
The average daily urine volume during baseline was not different among the groups and salt loading increased urine output comparably in both Salt SCR and Salt shBDNF rats ( Figure 4B ). Food intake was significantly decreased in both groups of salt loaded rats compared to the euhydrated rats ( Figure 4C ). Concomitantly, the average body weight increase during salt loading was significantly decreased in both Salt SCR and Salt shBDNF rats compared to the euhydrated rats (F 3,36 = 27.48, P < 0.001; Bonferroni t tests, P < 0.05) ( Figure 4D ).
| Changes in electrolyte excretion
Urine sodium excretion was measured before and during the 7-day salt loading protocol. Average daily changes in sodium excretion were significantly affected by time and the treatment protocol (F 39,312 = 35.65, P < 0.001) ( Figure 5A ). There were no differences among the groups during baseline. During salt loading, daily average change in sodium excretion significantly increased in the Salt SCR rats compared to the two euhydrated control groups (Bonferroni t tests, all P < 0.05) ( Figure 5A ). The daily changes in sodium excretion following BDNF knockdown in the SON were significantly increased during the 7-day salt loading compared to all the other groups (Bonferroni t tests, P < 0.05) ( Figure 5A ). Knockdown of BDNF in the SON also significantly increased total average daily sodium concentration (F 3,32 = 43.55, P < 0.001) ( Figure 5B ). The average daily urine sodium concentrations of salt loaded rats were significantly higher than the euhydrated groups during salt treatment. In addition, the Salt shBDNF group showed significantly higher urine sodium excretion than the Salt SCR rats (Bonferroni t tests, all P < 0.05) ( Figure 5B ).
| Changes in plasma AVP, osmolality and volume
One-way ANOVA revealed significant difference between the groups in plasma AVP concentration (F 3,18 = 26.227, P < 0.05). Bonferroni multiple comparisons show that rats with SCR injections and salt loading had significantly increased circulating AVP compared to all the other groups (Bonferroni t tests, all P < 0.001) ( Table 2 ). Knockdown of BDNF in the SON of salt loaded rats significantly decreased plasma AVP compared to the Salt SCR group (Bonferroni t = 6.661, P < 0.05) ( Table 2) . Plasma osmolality and haematocrit values were significantly different between the groups (plasma osmolality F 3,47 = 20.746, P < 0.001; hematocrit F 3,47 = 18.478, P < 0.001). The Salt SCR rats also had plasma osmolality and haematocrit values that were significantly higher than all other groups (Bonferroni t tests, all P < 0.05).
The Salt shBDNF group had significantly lower plasma osmolality (Bonferroni t = 4.146, P < 0.05) ( Table 2 ) and haematocrit (Bonferroni t = 3.708, P < 0.05) ( Table 2 ) compared to the Salt SCR group.
| Changes in MAP and heart rate
Two-way repeated measures ANOVA revealed a significant interaction indicating that MAP was affected by time and the treatment F I G U R E 3 A, Sample western blot images showing changes in protein expression of supraoptic nucleus (SON) punches. mCherry protein expression images shows successful injections at SON B, Quantification of phosphorylated tyrosine receptor kinase B (TrkB) (normalised to total TrkB). Data are the mean ± SEM. *P < 0.05 vs all other groups. + P < 0.05 vs salt scrambled (SCR). C, Phosphorylated KCC2 normalised to GAPDH. *P < 0.05 vs all other groups. Groups: euhydrated rats injected with SCR virus (Eu SCR, n = 6); euhydrated rats injected with shBDNF virus (Eu shBDNF, n = 6); salt loaded rats injected with SCR virus (Salt SCR, n = 8) and salt loaded rats injected with shBDNF virus (Salt shBDNF, n = 8) Post-hoc multiple comparisons between the factors revealed that there were no differences among the groups during baseline (Table 3) . Salt loading was associated with significant increases in MAP in rats injected in the SON with either SCR or shBDNF.
The MAP increases in the two salt loaded groups were not different from each other ( Figure 6A, B) . Two-way repeated measures ANOVA followed by post-hoc analysis show that salt loading was associated with a significant decrease in heart rate (Time × Treatment Table 3 ) that was no different between the SCR and shBDNF injected rats. and MAP associated with salt loading. Previous studies using this shBDNF viral construct have shown that its effects are primarily neurotrophic and that it produces stable knockdown of BDNF. Injections of shBDNF in the SON did not cause any changes in the volume of urine excretion or fluid and food intake behavior. Food intake and body weight in salt loaded groups were significantly decreased compared to the euhydrated groups. High salt intake caused the rats to decrease food intake and subsequently reduced body weight. 32 Although BDNF knockdown in the SON significantly attenuated AVP release in salt loaded rats, it did not similarly influence MAP. In the present study, MAP was significantly increased in the salt loaded groups compared to the euhydrated groups in accordance with previous studies. 19 These data indicate that mechanisms other than those involving AVP from the SON could contribute to the observed increase in MAP during high salt loading. Moreover, studies have shown that recruitment of central osmoreceptor pathways enhances sympathetic tone through excitation of preautonomic neurones. 19, 33 Another factor that could have influenced these results is the experimental protocol.
| D ISCUSS I ON
The AAV treatments were applied only to the SON. AVP dendritically released from magnocellular secretory neurones in the PVN has been shown to increase sympathetic outflow. 34 This mechanism would not have been influenced by the AAV injections in the SON and could still contribute to the increase in MAP associated with salt loading. Also, BDNF knockdown was induced before the rats were exposed to salt F I G U R E 6 Effect of salt loading and brain-derived neurotrophic factor (BDNF) knockdown in the supraoptic nucleus (SON). A, Daily average changes in mean arterial pressure (MAP). *P < 0.05 vs baseline and euhydrated (Eu) groups. B, Average changes in MAP. *P < 0.05 vs Eu groups. C, Daily average changes in heart rate (HR). *P < 0.05 vs baseline.
+ P < 0.05 vs Eu scrambled (SCR). D, Average changes in HR.
Data are the mean ± SEM. *P < 0.05 vs Eu groups. Groups: euhydrated rats injected with scrambled (SCR) virus (Eu SCR, n = 9); euhydrated rats injected with shBDNF virus (Eu shBDNF, n = 9); salt loaded rats injected with SCR virus (Salt SCR, n = 9) and salt loaded rats injected with shBDNF virus (Salt shBDNF, n = 9) TA B L E 3 Absolute mean arterial pressure (MAP) and heart rate in euhydrated rats injected with the control vector (Eu scrambled [SCR]), euhydrated rats injected with shRNA against brain-derived neurotrophic factor (BDNF) (Eu shBDNF), salt loaded rats injected with control vector (Salt SCR), and salt loaded rats injected with shRNA against BDNF (Salt shBDNF) groups loading. This was carried out because the time required to allow the AAV to transfect the cells in the SON is longer than the 7-day salt loading protocol. As noted above, this protocol significantly reduced AVP release, although it did not prevent the increase in MAP. It could be that mechanisms related to autonomic function, which do not depend on the SON, were able to compensate for the lack of AVP release. 
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This could be the mechanism responsible for the change in the va- The present study advances our understanding about the pathophysiology of AVP neurone regulation. Identifying the source of BDNF underlying the changes in postsynaptic inhibition of AVP neurones in response to salt loading may result in novel strategies for reducing AVP secretion in other pathological states, such as heart and liver failure. 9, 16, 42 This would provide a novel therapeutic target for the treatment of inappropriate AVP release and its associated morbidities.
